UCSF Department of Bioengineering and Therapeutic Sciences (BTS)

United States of America (USA)

1 October 2019 - 30 September 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for UCSF Department of Bioengineering and Therapeutic Sciences (BTS) published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: UCSF Department of Bioengineering and Therapeutic Sciences (BTS) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
53 9.76

Outputs by subject (Share)

Subject Count Share
Chemistry 10 2.59
Life Sciences 44 7.19
Physical Sciences 12 2.53
ACS Nano 3 0.58
Advanced Functional Materials 3 1.26
Nature 1 0.27
Nature Medicine 1 0.01
Proceedings of the National Academy of Sciences of the United States of America 3 0.21
Science Advances 1 0.19

1 October 2019 - 30 September 2020

International vs. domestic collaboration by Share

  • 80.67% Domestic
  • 19.33% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (113 total)

  • UCSF Department of Bioengineering and Therapeutic Sciences (BTS), United States of America (USA)
  • Domestic institution
  1. University of California, Berkeley (UC Berkeley), United States of America (USA) (13.47)
    4.10
    9.37
  2. Chan Zuckerberg Biohub (CZ Biohub), United States of America (USA) (4.48)
    3.41
    1.07
  3. Stanford University, United States of America (USA) (2.65)
    0.80
    1.85
  4. California Institute for Quantitative Biosciences (QB3), United States of America (USA) (2.08)
    1.36
    0.72
  5. Stanford Department of Bioengineering, United States of America (USA) (1.49)
    0.69
    0.80
  6. Lawrence Berkeley National Laboratory (LBNL), United States of America (USA) (1.34)
    0.47
    0.87
  7. Harvard University, United States of America (USA) (1.33)
    0.49
    0.83
  8. University of California, Irvine (UCI), United States of America (USA) (1.16)
    0.61
    0.55
  9. University of Washington (UW), United States of America (USA) (1.14)
    0.28
    0.85
  10. Florida International University (FIU), United States of America (USA) (1)
    0.17
    0.83

Top 10 international collaborators by Share (73 total)

  • UCSF Department of Bioengineering and Therapeutic Sciences (BTS), United States of America (USA)
  • Foreign institution
  1. University of Ottawa (uOttawa), Canada (0.94)
    0.28
    0.67
  2. Shanghai Ocean University (SHOU), China (0.56)
    0.13
    0.44
  3. University of Cambridge, United Kingdom (UK) (0.54)
    0.09
    0.45
  4. Novartis International AG, Switzerland (0.52)
    0.10
    0.42
  5. Pasteur Institute, France (0.50)
    0.31
    0.20
  6. Zhejiang University (ZJU), China (0.44)
    0.13
    0.31
  7. Wellcome Sanger Institute, United Kingdom (UK) (0.39)
    0.08
    0.31
  8. University of Sassari (UniSS), Italy (0.34)
    0.18
    0.16
  9. Xi'an Jiaotong University (XJTU), China (0.31)
    0.18
    0.13
  10. University of Regensburg (UR), Germany (0.31)
    0.18
    0.13

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

UCSF Department of Bioengineering and Therapeutic Sciences (BTS)

Participating institutions

UCSF Department of Bioengineering and Therapeutic Sciences (BTS) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Affiliated joint institutions and consortia

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER